Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood

Infection. 1983 Sep-Oct;11(5):255-9. doi: 10.1007/BF01641256.

Abstract

The results of immunosuppressive treatment (a corticosteroid-azathioprine combination) in 104 children suffering from chronic HBsAg-positive hepatitis are reviewed. A recovery and/or improvement of the majority of the cases treated was observed after two to seven years of therapy, in contradiction to the opinion of other authors who treated adult patients. A biochemical and/or bioptic deterioration was observed in some cases in which treatment was interrupted too soon; this was followed by an improvement when treatment was re-initiated. No serious side-effects were observed with the combination treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use*
  • Azathioprine / therapeutic use*
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Hepatitis B / drug therapy*
  • Hepatitis B Surface Antigens
  • Hepatitis, Chronic / drug therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Prednisolone / therapeutic use
  • Prednisone / adverse effects
  • Prednisone / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Hepatitis B Surface Antigens
  • Immunosuppressive Agents
  • Prednisolone
  • Azathioprine
  • Prednisone